<DOC>
	<DOCNO>NCT01322581</DOCNO>
	<brief_summary>Plasmodium falciparum ( Pf ) malaria remain major cause morbidity mortality worldwide . A malaria vaccine would contribute towards effort control eliminate malaria . Optimism effective malaria vaccine develop derive part observation repeat Pf infection induce protective immunity ; however , mechanism underlie acquire malaria immunity remain unclear . The goal current study apply system biological tool observational cohort area intense seasonal Pf transmission gain insight mechanism underlie naturally acquire malaria immunity . This year-long observational-cohort study 700 individual ( 3 month 25 year age ) conduct rural village Kalifabougou , Mali , Pf transmission intense seasonal . Asymptomatic Pf infection malaria episode detect passive active surveillance . Immune parameter malaria-protected -susceptible individual assay blood sample collect strategic time point relative malaria season . The primary objective identify genome-wide expression profile induce Pf infection associate protection malaria . Secondary objective include identify age-related ( surrogate cumulative Pf exposure ) change Pf-induced gene-expression serum cytokine profile , examine Pf-specific antibody profile associate protection malaria use protein microarray represent 2000 Pf protein ( 40 percent Pf proteome ) . Exploratory objective study compare magnitude quality Pf-specific CD4 plus T cell response malaria-protected -susceptible individual determine response varies age among individual , , malaria season , well compare various immune parameter Pf-infected uninfected individual end dry season investigate host immune factor associate chronic asymptomatic Pf infection .</brief_summary>
	<brief_title>A Longitudinal Systems Biological Analysis Naturally Acquired Malaria Immunity Mali</brief_title>
	<detailed_description>Plasmodium falciparum ( Pf ) malaria remain major cause morbidity mortality worldwide . A malaria vaccine would contribute towards effort control eliminate malaria . Optimism effective malaria vaccine develop derive part observation repeat Pf infection induce protective immunity ; however , mechanism underlie acquire malaria immunity remain unclear . The goal current study apply system biological tool observational cohort area intense seasonal Pf transmission gain insight mechanism underlie naturally acquire malaria immunity . This observational-cohort study individual ( 3 month 40 year age ) conduct rural village Kalifabougou , Mali , Pf transmission intense seasonal . Asymptomatic Pf infection malaria episode detect passive active surveillance . Immune parameter malaria-protected -susceptible individual assay blood sample collect strategic time point relative malaria season . The primary objective identify genome-wide expression profile induce Pf infection associate protection malaria . Secondary objective include identify age-related ( surrogate cumulative Pf exposure ) change Pf-induced gene-expression serum cytokine profile , examine Pf-specific antibody profile associate protection malaria use protein microarray represent 2000 Pf protein ( approximately 40 % Pf proteome ) . Exploratory objective study compare magnitude quality Pf-specific CD4+ T cell response malaria-protected -susceptible individual determine response varies age among individual , , malaria season , well compare various immune parameter Pf-infected uninfected individual end dry season investigate host immune factor associate chronic asymptomatic Pf infection .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>INCLUSION CRITERIA : Individuals 3 month 40 year age eligible enter study agree : Live Kalifabougou duration study ( 12 month ) . Have blood specimen store future study . EXCLUSION CRITERIA : The follow eligibility criterion exclusionary : Anemia ( hemoglobin le 7 g/dL ) . Current use antimalarial , corticosteroid , immunosuppressant . Underlying heart disease , bleed disorder , condition , judgment clinical investigator , could increase risk study subject . Fever great equal 37.5 degree Celsius evidence acute infection . Currently pregnant plan become pregnant study period . ( Asymptomatic Pf infection enrollment exclusionary ) .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 16, 2017</verification_date>
	<keyword>Plasmodium Falciparum</keyword>
	<keyword>Genome-Wide Expression</keyword>
	<keyword>Antibody Profiling Protein Microarray</keyword>
	<keyword>Multiplex Cytokine Analysis</keyword>
	<keyword>Children Adults</keyword>
	<keyword>Malaria</keyword>
</DOC>